Role of glia in delirium: proposed mechanisms and translational implications

Delirium is a common acute onset neurological syndrome characterised by transient fluctuations in cognition. It affects over 20% of medical inpatients and 50% of those critically ill. Delirium is associated with morbidity and mortality, causes distress to patients and carers, and has significant soc...

Full description

Bibliographic Details
Main Authors: Heffernan, ÁB, Steinruecke, M, Dempsey, G, Chandran, S, Selvaraj, BT, Jiwaji, Z, Stavrou, M
Format: Journal article
Language:English
Published: Springer Nature [academic journals on nature.com] 2024
_version_ 1824459354573635584
author Heffernan, ÁB
Steinruecke, M
Dempsey, G
Chandran, S
Selvaraj, BT
Jiwaji, Z
Stavrou, M
author_facet Heffernan, ÁB
Steinruecke, M
Dempsey, G
Chandran, S
Selvaraj, BT
Jiwaji, Z
Stavrou, M
author_sort Heffernan, ÁB
collection OXFORD
description Delirium is a common acute onset neurological syndrome characterised by transient fluctuations in cognition. It affects over 20% of medical inpatients and 50% of those critically ill. Delirium is associated with morbidity and mortality, causes distress to patients and carers, and has significant socioeconomic costs in ageing populations. Despite its clinical significance, the pathophysiology of delirium is understudied, and many underlying cellular mechanisms remain unknown. There are currently no effective pharmacological treatments which directly target underlying disease processes. Although many studies focus on neuronal dysfunction in delirium, glial cells, primarily astrocytes, microglia, and oligodendrocytes, and their associated systems, are increasingly implicated in delirium pathophysiology. In this review, we discuss current evidence which implicates glial cells in delirium, including biomarker studies, post-mortem tissue analyses and pre-clinical models. In particular, we focus on how astrocyte pathology, including aberrant brain energy metabolism and glymphatic dysfunction, reactive microglia, blood-brain barrier impairment, and white matter changes may contribute to the pathogenesis of delirium. We also outline limitations in this body of work and the unique challenges faced in identifying causative mechanisms in delirium. Finally, we discuss how established neuroimaging and single-cell techniques may provide further mechanistic insight at pre-clinical and clinical levels.
first_indexed 2025-02-19T04:40:27Z
format Journal article
id oxford-uuid:285c25b7-f1c7-4342-b152-8ae1a04220aa
institution University of Oxford
language English
last_indexed 2025-02-19T04:40:27Z
publishDate 2024
publisher Springer Nature [academic journals on nature.com]
record_format dspace
spelling oxford-uuid:285c25b7-f1c7-4342-b152-8ae1a04220aa2025-02-18T20:13:18ZRole of glia in delirium: proposed mechanisms and translational implicationsJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:285c25b7-f1c7-4342-b152-8ae1a04220aaEnglishJisc Publications RouterSpringer Nature [academic journals on nature.com]2024Heffernan, ÁBSteinruecke, MDempsey, GChandran, SSelvaraj, BTJiwaji, ZStavrou, MDelirium is a common acute onset neurological syndrome characterised by transient fluctuations in cognition. It affects over 20% of medical inpatients and 50% of those critically ill. Delirium is associated with morbidity and mortality, causes distress to patients and carers, and has significant socioeconomic costs in ageing populations. Despite its clinical significance, the pathophysiology of delirium is understudied, and many underlying cellular mechanisms remain unknown. There are currently no effective pharmacological treatments which directly target underlying disease processes. Although many studies focus on neuronal dysfunction in delirium, glial cells, primarily astrocytes, microglia, and oligodendrocytes, and their associated systems, are increasingly implicated in delirium pathophysiology. In this review, we discuss current evidence which implicates glial cells in delirium, including biomarker studies, post-mortem tissue analyses and pre-clinical models. In particular, we focus on how astrocyte pathology, including aberrant brain energy metabolism and glymphatic dysfunction, reactive microglia, blood-brain barrier impairment, and white matter changes may contribute to the pathogenesis of delirium. We also outline limitations in this body of work and the unique challenges faced in identifying causative mechanisms in delirium. Finally, we discuss how established neuroimaging and single-cell techniques may provide further mechanistic insight at pre-clinical and clinical levels.
spellingShingle Heffernan, ÁB
Steinruecke, M
Dempsey, G
Chandran, S
Selvaraj, BT
Jiwaji, Z
Stavrou, M
Role of glia in delirium: proposed mechanisms and translational implications
title Role of glia in delirium: proposed mechanisms and translational implications
title_full Role of glia in delirium: proposed mechanisms and translational implications
title_fullStr Role of glia in delirium: proposed mechanisms and translational implications
title_full_unstemmed Role of glia in delirium: proposed mechanisms and translational implications
title_short Role of glia in delirium: proposed mechanisms and translational implications
title_sort role of glia in delirium proposed mechanisms and translational implications
work_keys_str_mv AT heffernanab roleofgliaindeliriumproposedmechanismsandtranslationalimplications
AT steinrueckem roleofgliaindeliriumproposedmechanismsandtranslationalimplications
AT dempseyg roleofgliaindeliriumproposedmechanismsandtranslationalimplications
AT chandrans roleofgliaindeliriumproposedmechanismsandtranslationalimplications
AT selvarajbt roleofgliaindeliriumproposedmechanismsandtranslationalimplications
AT jiwajiz roleofgliaindeliriumproposedmechanismsandtranslationalimplications
AT stavroum roleofgliaindeliriumproposedmechanismsandtranslationalimplications